Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis.

J Intern Med · 2021 · PMC8246813 · PMID 33258193

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A third example is a relatively large placebo‐controlled phase II trial with a DNA vaccine encoding MBP, which only showed a trend towards a beneficial effect in one of the dose groups [ 147 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.